NeoStem (NBS) Appoints Lead Investigator on NBS20 Phase 3 in Certain Metastatic Melanoma
Tweet Send to a Friend
NeoStem (NASDAQ: NBS) announced the appointment of Dr. Merrick Ross, Professor of Surgery and Chief of the Melanoma Section, Department ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE